Author Archives: Warren Woessner

Supreme Court Denies Cert. in Vanda, Berkheimer and Athena

Posted on January 13, 2020 by Warren Woessner

This morning, the Supreme Court denied the petitions for cert. filed in the Vanda, Berkheimer and Athena appeals. While the Court had requested and received amici briefs from the Solicitor General that opined that the Court should not grant cert. … Continue reading →

Posted in Supreme Court News | Tagged , , | Leave a comment

Hulu v. Soundview Innovations – the Shifting Sands of Printed Publications

Posted on January 10, 2020 by Warren Woessner

In Hulu v Soundview Innovations, IPR2018-01039, the PTAB was faced with the question of whether or not a certain textbook was a “printed publication” that was “publicly available” and so qualified as prior art against U.S. Pat. No. 5,806,062 – … Continue reading →

Posted in 102 Patentability, Prior Art | Tagged , , | Leave a comment

Solicitor General’s Briefs Encourage Supreme Court to Put s. 101 Back on Track

Posted on December 10, 2019 by Warren Woessner

Earlier this year, the Supreme Court issued orders to the Solicitor General to weigh in on whether or not the Court should grant cert. in two high profile Fed. Cir. decisions: Hikma Pharm. USA Inc, v. Vanda Pharm. Inc., No. … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , | Leave a comment

Nuvo Pharms. v. Dr. Reddy’s Labs. – Catch 22 at the Federal Circuit?

Posted on November 21, 2019 by Warren Woessner

A “catch 22” is defined as a “dilemma or difficult circumstance from which there is no escape because of mutually conflicting or dependent conditions.” (As in if a pilot claims he is too mentally ill to fly missions, he has … Continue reading →

Posted in Federal Circuit, Prior Art | Tagged , | Leave a comment